Zhitong Financial App News, Huisheng Biological (300871.SZ) issued an announcement The company recently received shareholders Shenzhen Innovation Investment Group Co., Ltd. (referred to as "Deep Venture Capital") and its concerted actors Shenzhen laterite Biological Venture Capital Co., Ltd. (referred to as "laterite biology"). Hubei laterite Venture Capital Co., Ltd. (Hubei laterite Venture Capital Co., Ltd.), Wuhan laterite Innovation Venture Capital Co., Ltd. (Wuhan laterite Innovation Venture Capital Co., Ltd.) issued a letter of notification on the progress of the shareholder reduction plan. The reduction plan has been implemented for more than half of the time.
As of the date of disclosure of this announcement, the company's shareholders Deep Venture Capital and its concerted actors, laterite biology, Hubei laterite and Wuhan laterite, have reduced their holdings of 4.9875 million shares of the company through centralized bidding transactions, accounting for 3.00% of the total share capital of the company.